A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study (Q43264777)
Jump to navigation
Jump to search
scientific article published on 9 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study |
scientific article published on 9 October 2009 |
Statements
1 reference
A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study (English)
1 reference
Toshio Ogihara
1 reference
Takao Saruta
1 reference
Kazuyuki Shimada
1 reference
Kizuku Kuramoto
1 reference
9 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference